Skip to main content
logo
BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1845
-0.0162 (-8.07%)
At close: Feb 11, 2026, 4:00 PM EST
0.1930
+0.0085 (4.61%)
After-hours: Feb 11, 2026, 6:10 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '21 Dec '20 Dec '19 Dec '18
Antibody-based Products
11.00M
Antibody-based Products Growth
4300.00%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '21 Dec '20 Dec '19 Dec '18
United States
11.00M
United States Growth
4300.00%